Description of Sbc Medical Group Holdings Incorporated's Business Segments
The Company operates in a single segment, generating revenue primarily through comprehensive management services for franchisee cosmetic treatment centers. These services include advertising, staffing, procurement, IT solutions, and licensing of medical technologies and trademarks. The Company wholly owns SBC Medical Group, Inc. and SBC MEDICAL APAC PTE. LTD. SBC Medical Group, Inc. operates through 15 wholly owned subsidiaries—SBC Medical Group Co., Ltd., Liesta Co., Ltd., SBC Sealane Co., Ltd., SBC Marketing Co., Ltd., SBC Medical Consulting Co., Ltd., Shoubikai Medical Vietnam Co. Ltd., SBC Healthcare, Inc., SBC Irvine, LLC, Aesthetic Healthcare Holdings Pte., Ltd., Wen & Weng Family Clinic Pte., Ltd., Wen & Weng Medical Group Pte., Ltd., Rochor Clinic Pte., Ltd., Dermasolutions Pte., Ltd., Dermasolutions Services Pte., Ltd., and MB Career Lounge Co., Ltd.—and three majority owned subsidiaries: Medical Payment Co., Ltd., Waqoo, Inc., and Cell Pro Japan Co., Ltd., the latter being a wholly owned subsidiary of Waqoo. The Company also consolidates Aikawa Medical Management, Inc., its variable interest entity. Effective January 1, 2026, SBC Marketing Co., Ltd. merged into SBC Medical Group Co., Ltd. On January 7, 2026, the Company established SBC Medical M&A Advisory Co., Ltd. to provide healthcare-focused M&A advisory services. The Company sold its subsidiaries Kijimadaira Resort Inc. and Skynet Academy Co., Ltd. to entities owned by Yoshiyuki Aikawa, CEO, to focus on its core medical business; these disposals did not constitute a strategic shift with significant effects on operations or financial results.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.